Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.

Wattmo C, Londos E, Minthon L.

BMC Neurol. 2014 Sep 10;14:173. doi: 10.1186/s12883-014-0173-4.

2.

The prediction of response to galantamine treatment in patients with mild to moderate Alzheimer's disease.

Ohnishi T, Sakiyama Y, Okuri Y, Kimura Y, Sugiyama N, Saito T, Takahashi M, Kobayashi T.

Curr Alzheimer Res. 2014 Feb;11(2):110-8.

3.

Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response.

Sabbagh M, Cummings J, Christensen D, Doody R, Farlow M, Liu L, Mackell J, Fain R.

BMC Geriatr. 2013 Jun 6;13:56. doi: 10.1186/1471-2318-13-56.

4.

Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort.

Wattmo C, Wallin AK, Minthon L.

BMC Neurol. 2012 Nov 5;12:134. doi: 10.1186/1471-2377-12-134.

5.

Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting.

Wallin AK, Wattmo C, Minthon L.

Neuropsychiatr Dis Treat. 2011;7:565-76. doi: 10.2147/NDT.S24196. Epub 2011 Sep 30.

6.

Rivastigmine in the treatment of patients with Alzheimer's disease.

Müller T.

Neuropsychiatr Dis Treat. 2007 Apr;3(2):211-8.

7.

Economic considerations in the management of Alzheimer's disease.

Zhu CW, Sano M.

Clin Interv Aging. 2006;1(2):143-54. Review.

8.
9.

Predicting the outcome of cholinesterase inhibitor treatment in Alzheimer's disease.

Connelly PJ, Prentice NP, Fowler KG.

J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):320-4.

10.
11.

Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease.

Rockwood K.

J Neurol Neurosurg Psychiatry. 2004 May;75(5):677-85. Review. Erratum in: J Neurol Neurosurg Psychiatry. 2004 Jul;75(7):1086.

12.

Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.

Lanctôt KL, Herrmann N, Yau KK, Khan LR, Liu BA, LouLou MM, Einarson TR.

CMAJ. 2003 Sep 16;169(6):557-64. Review.

13.

Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.

Lanctôt KL, Herrmann N, LouLou MM.

J Psychiatry Neurosci. 2003 Jan;28(1):13-26. Review.

Supplemental Content

Support Center